[1]
“TARGETING OF NANOCARRIERS FOR CHEMOTHERAPY OF TUBERCULOSIS”, Int J of Biomed & Adv Res, vol. 2, no. 9, pp. 291–308, Oct. 2011, doi: 10.7439/ijbar.v2i9.43.